University Hospital of Geneva (HUG)
Welcome,         Profile    Billing    Logout  
 0 Trials 
6 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Neofytos, Dionysios
BIMI, NCT04720144: Breakthrough Invasive Mold Infections Under Posaconazole Prophylaxis

Recruiting
N/A
300
Europe
Centre Hospitalier Universitaire Vaudois
Invasive Mold Infections, Breakthrough Invasive Mold Infections, Hematologic Malignancy, Hematologic Diseases
09/22
09/22
TAK-620-5010, NCT06615921: A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection

Recruiting
N/A
150
Europe, RoW
No Intervention
Takeda
Cytomegalovirus (CMV)
04/25
04/25
PTX3 AML, NCT03828773: PTX3-targeted Antifungal Prophylaxis

Recruiting
N/A
320
Europe
Posaconazole, Noxafil, Fluconazole, Diflucan
Bochud Pierre-Yves, Swiss National Science Foundation
Candidiasis, Fungal Infection, Acute Myeloid Leukemia, Genetic Predisposition, Aspergillosis
11/25
11/25
Erard, Véronique
NCT04836260: Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19

Recruiting
3
100
Europe
SARS-CoV-2 convalescent plasma
University Hospital, Geneva, University Hospital, Basel, Switzerland, Ospedale Regionale di Lugano, Hôpital Fribourgeois
Covid19, Immuno-Deficiency, Old Age; Debility
12/21
12/21
BIMI, NCT04720144: Breakthrough Invasive Mold Infections Under Posaconazole Prophylaxis

Recruiting
N/A
300
Europe
Centre Hospitalier Universitaire Vaudois
Invasive Mold Infections, Breakthrough Invasive Mold Infections, Hematologic Malignancy, Hematologic Diseases
09/22
09/22
PTX3 AML, NCT03828773: PTX3-targeted Antifungal Prophylaxis

Recruiting
N/A
320
Europe
Posaconazole, Noxafil, Fluconazole, Diflucan
Bochud Pierre-Yves, Swiss National Science Foundation
Candidiasis, Fungal Infection, Acute Myeloid Leukemia, Genetic Predisposition, Aspergillosis
11/25
11/25

Download Options